Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$24.22 - $60.60
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Latest price
Market Cap | $2.83B |
EV | $2.29B |
Shares Outstanding | 65.95M |
Beta | 2.29 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $69.10 |
P/E 2025E | - |
P/Revenue 2025E | 28.68x |
Revenue | 151.40% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | -32.00% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | -82.46% |
ROE 2025E | -22.20% |
ROCE 2024 | 54.39% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Protagonist Therapeutics, Inc.
PTGX
Sector
Healthcare
Industry
Biotechnology
CEO
Patel, Dinesh
Employees
126
Website
www.protagonist-inc.comIPO Date
2016-08-11
Headquarters
7707 Gateway Boulevard, Suite 140, Newark, California, 94560-1160, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved